Familial amyloidotic polyneuropathy type I (FAP) is an autosomal dominant hereditary disease with high prevalence in the northern part of Portugal and is caused by the systemic deposition of a variant of transthyretin (TTR V30M) (Costa et al., 1978) . Specific removal of TTR from plasma in an extracorporeal immunoapheresis procedure (Regnault et al., 1992) has been under investigation as a possible treatment for FAP. The high costs related to the production and purification of the anti-TTR monoclonal antibodies has prompted us to develop immunoadsorbents based on single-chain antibody fragments (scFvs).
Using phage display technology we isolated 4 anti-TTR scFvs from the human combinatorial V H + V L phagemid library "Griffin.1." (Griffiths et al., 1994) which were expressed in E. coli suppressor strain ER2537 up to 10 mg/ml. Since the construction of an immunoadsorbent requires several grams of purified anti-TTR scFv, an attempt was made to express these scFvs in high yields using Pichia pastoris (Cereginho and Cregg, 2000) .
Anti-TTR scFv-D was subcloned from the phagemid pHEN2 into the vectors pPICZ␣B and pGAPZ␣B for the expression under the control of the methanol-regulated AOX1 promotor, and the constitutive glyceraldehyde-3-phosphate dehydrogenase promoter, respectively. Presence of scFv insert was confirmed by PCR, and the recombinant plasmids were propagated in E. coli TOP10F . P. pastoris X33 (Mut + ) was transformed with the linearized plasmids by electroporation, and transformants were selected on YPD plates + 100 g/ml zeocin. Several clones were tested for the highest scFv production under standard conditions (30 • C, 6 days, unbuffered medium) and the clones with the highest level of anti-TTR scFv expression were used for fur-
